InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results
Provided By GlobeNewswire
Last update: Mar 12, 2025
MIAMI, March 12, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced financial and operating results for the fourth quarter and full year ended December 31, 2024.
Read more at globenewswire.com
